DRIO
DarioHealth Corp

3,551
Mkt Cap
$67.14M
Volume
50,742.00
52W High
$31.00
52W Low
$5.94
PE Ratio
-0.65
DRIO Fundamentals
Price
$11.73
Prev Close
$9.92
Open
$9.92
50D MA
$12.61
Beta
1.10
Avg. Volume
34,088.87
EPS (Annual)
-$12.27
P/B
1.06
Rev/Employee
$133,861.39
Loading...
Loading...
News
all
press releases
DarioHealth Corp. (DRIO) Reports Q3 Loss, Lags Revenue Estimates
DarioHealth (DRIO) delivered earnings and revenue surprises of +29.66% and -12.47%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2d ago
News Placeholder
More News
News Placeholder
DarioHealth Reports Third Quarter 2025 Financial and Operating Results
DarioHealth Reports Third Quarter 2025 Financial and Operating Results DarioHealth Reports Third Quarter 2025 Financial and Operating Results PR Newswire NEW YORK, Nov. 13, 2025 Third quarter 2025...
PR Newswire·2d ago
News Placeholder
Examining the Future: DarioHealth's Earnings Outlook
read more...
Benzinga·3d ago
News Placeholder
Lucid Diagnostics Inc. (LUCD) Reports Q3 Loss, Lags Revenue Estimates
Lucid Diagnostics (LUCD) delivered earnings and revenue surprises of -66.67% and -6.85%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
DarioHealth Presents New Data Demonstrating Significant Reduction in Medical Costs Among Employer Populations Using Its Digital Health Platform
DarioHealth Presents New Data Demonstrating Significant Reduction in Medical Costs Among Employer Populations Using Its Digital Health Platform DarioHealth Presents New Data Demonstrating Significant...
PR Newswire·3d ago
News Placeholder
Si-Bone (SIBN) Reports Q3 Loss, Beats Revenue Estimates
Si-Bone (SIBN) delivered earnings and revenue surprises of +31.25% and +4.25%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4d ago
News Placeholder
DarioHealth to Report Third Quarter 2025 Results on Thursday, November 13, 2025
DarioHealth to Report Third Quarter 2025 Results on Thursday, November 13, 2025 DarioHealth to Report Third Quarter 2025 Results on Thursday, November 13, 2025 PR Newswire NEW YORK, Nov. 6, 2025...
PR Newswire·9d ago
News Placeholder
Orthofix (OFIX) Beats Q3 Earnings and Revenue Estimates
Orthofix (OFIX) delivered earnings and revenue surprises of +66.67% and +2.65%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·11d ago
News Placeholder
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of DarioHealth Corp. (NASDAQ: DRIO)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of DarioHealth Corp. (NASDAQ: DRIO) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...
PR Newswire·17d ago
News Placeholder
Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition
MMSI is set to acquire C2 CryoBalloon from Pentax for $22M, strengthening its GI portfolio. Despite near-term dilution, the deal positions Merit for long-term growth in gastroenterology.
Zacks·30d ago

Latest DRIO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.